[Treatment of Dupuytren's disease; limited fasciectomy versus percutaneous needle fasciotomy].

OBJECTIVE

We estimated retreatment risk following limited fasciectomy (LF) or percutaneous needle fasciotomy (PNF) for Dupuytren's disease.

DESIGN

Prospective cohort study.

METHOD: Using frailty models, we estimated retreatment risk within 1,3,5,10 and 20 years.

RESULTS

LF showed a 10-year retreatment risk of 8% (95%CI: 3-13%) for men and 4% (95%CI: 1-8%) for women without an affected first-degree relative, initially treated at 60 years. PNF showed higher risks at 69% (95%CI: 52-86%) and 46% (95%CI: 16-77%). Younger age at initial treatment increased retreatment risk, sex and first-degree relative had no influence.

CONCLUSION

LF gives a longer-lasting treatment effect than PNF.